Nimish Gera

Nimish joined Mythic Therapeutics in October 2017 as the scientific co-founder and director of R & D and now serves as Head of Biologics, overseeing antibody discovery, engineering, optimization, and cell-based screening technologies.

Nimish’s broad experience in biotech encompasses various modalities (monoclonal antibodies, bispecific antibodies, protein-fusions, and antibody-drug conjugates) and therapeutic areas (oncology, immuno-oncology, autoimmune, and rare disease). Nimish served as a scientist and project leader at Alexion Pharmaceuticals where he led and managed diverse cross-functional project teams to lead two antibody discovery programs into development. Prior to Alexion, Nimish helped establish discovery sciences functionality at Oncobiologics (now Outlook Therapeutics) and identified multiple lead candidates for the company’s platform.

He earned a Ph.D. in chemical and biomolecular engineering with a minor in biotechnology at North Carolina State University.